Mar 21 |
Argenx gains after setback to Roche/Chugai myasthenia gravis therapy
|
Mar 19 |
Reasons to Invest in argenx (ARGX)
|
Mar 7 |
argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting
|
Mar 7 |
Ascendis Pharma A/S (ASND) Faced R&D Setbacks in Q4
|
Mar 7 |
Should You be Confident in Your Investment in argenx SE (ARGX)?
|
Mar 1 |
argenx SE (NASDAQ:ARGX) Q4 2023 Earnings Call Transcript
|
Feb 29 |
argenx SE (ARGX) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Earnings Scheduled For February 29, 2024
|
Feb 29 |
Argenx SE GAAP EPS of -$1.68 misses by $0.30, revenue of $374M beats by $10.28M
|
Feb 29 |
argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
|